We have previously used gamma-irradiated MART-1 expressing melanomacells as a source of antigens to vaccinate melanoma patients by injectingirradiated cells with BCG and GM-CSF or to load immature DC and use them asa vaccine. This evidence concerns the gene CSF2 and melanoma.